Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection

World News: . []

WALTHAM Mass March 12 2018 GLOBE NEWSWIRE -- Radius Health Inc NasdaqRDUS a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteopo...

More news and information about Radius Health Inc.

Published By:

Globe Newswire: 20:30 GMT Monday 12th March 2018

Published: .

Search for other references to "radius" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us